Korsana Biosciences Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026

Company Profile

IndustryBiotechnology

SectorHealthcare

ExchangeNASDAQ

Market Capitalization1,522.45 mln

Float41.50 mln

1-Year Forecast

44.00

Exceptional upside

Relative Strength

29 / 100

Underperforming

Debt / Equity

0.01

Debt-free

Pre-Tax Margin

-353%

Severely loss-making

ROE

-85.83

Deeply negative

ROA

-74.18

Deeply negative

Business Description

Korsana Biosciences Inc. is a young biotech firm founded in 2024 and headquartered in Waltham, Massachusetts. The company focuses on finding and building new treatments for diseases that cause progressive damage to the nervous system.

Key Fundamentals

EPS-7.07

ROE-85.83

RPS3.13

ROIC-121

ROA-74.18

EBITDA, mln-6.71

EV / EBITDA-218

EV / EBIT-218

Revenue, mln1.90

EV / Revenue771

Quote Details

Last 31.31

Change -2.12 (-6.34%)

Open 34.16

Volume 402,007

Turnover 12,586,839

Average Volume 122,976

Financial Ratios

Pre-Tax Profit Margin-353

Leverage Ratio1.36

Current Ratio0.82

Price / Book3.85

Price / Tangible Book3.85

Debt / Equity0.01

Price / Sales8.53

Financial Strength

1-Year Target Price44.00

Short Ratio0.14

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-3.3%	21 / 100
1 Month	-15.81%	22 / 100